Fighting Antimicrobial Resistance:
from the
Biological EmergencY to Opportunistic and Neglected Diseases
« Usually in movies, an alien lands in a new city (usually San Francisco for any reason) and, despite the efforts of hundreds of soldiers from the best army on the planet, it escapes every bullet we fire against it… Then, the heroine create a new weapon, by thinking a new strategy that has never been used before and kills the alien, making the city free again...»
Just like these aliens, bacteria can get away from most of the treatments we have in hospitals, and we call them multidrug-resistant bacteria or MDR. To face them, people are obstinate in generating next generation treatments by modifying known antibiotics... That’s why we must go FAR BEYOND… It is too late for the next steps, it is time for new weapons to face these "aliens", it is time for a new generation of antibiotics…
DimiCare works on a new class of precision antibiotics, a “magic bullet” that eliminates 100% of targeted multidrug-resistant bacteria, without any resistance to, later be degraded by the organism without any environmental impact.
Dimicare is a future spin-off from University Côte d'Azur (UniCA), INSERM and CNRS focused on the development of a new generation of drugs against difficult-to-treat infections. Thanks to our screening platform ARROW, we have discovered and characterized a new family of precision antibiotics with a high and specific efficacy, reduced resistant rate and undetectable ecological impact (reduced production impact, and no effect on microorganisms after degradation)...
Currently, our main project (DCB001) focuses on the development of a new precision treatment against MDR (multidrug-resistant) S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus).
Our Dream Team
DimiCare is building a great team involving academic researchers, infectiology and microbiology medical doctors, and strategic development experts, assuring a solid growth not only in the scientific but also in the business field.
Juan A. Garcia-Sanchez
PhD
CEO / CSO-temporary
Pauline Meola
MSc
CTO
Laurent Boyer
PhD
Head of Biology
Cyril Ronco
PhD
Head of Chemistry
Patrick Munro
PhD
Senior Microbiologist
Grégory Michel
PhD
Senior Microbiologist
O.D.
PhD
Business Developer
Christelle Pomares-Estran
MD, PhD
Clinical Parasitology Advisor
Raymond Ruimy
MD, PhD
Clinical Bacteriology Advisor
Johan Courjon
MD, PhD
Clinical Infectiology Advisor
DimiCare is promoting its new candidate and communicating about AMR therapies everytime! Get updated about the news concerning our technology and dream team!
Are you interested on our project?
Here are the different ways to contact us!
Legal Notice © Copyright. All rights reserved.
Nous avons besoin de votre consentement pour charger les traductions
Nous utilisons un service tiers pour traduire le contenu du site web qui peut collecter des données sur votre activité. Veuillez consulter les détails dans la politique de confidentialité et accepter le service pour voir les traductions.